ESC 365 - Metabolic alterations and post-translational modifications in the failing heart

Premium Access

Metabolic alterations and post-translational modifications in the failing heart

Session: The cardiometabolic syndrome and extracardiac drug effects beneficial to the heart

Topic: Drugs, Drug Targets

Speaker: Professor L. Bertrand (Brussels, BE)

Event: HFA Winter Research Meeting on Translational Heart Failure 2025

Seminar Presentation

Add to my library

About the speaker

Professor Luc Bertrand

Institute of Experimental and Clinical Research (IREC), Brussels (Belgium)

4 presentations

0 follower

3 more presentations in this session

Off target effects of SGLT2-inhibitors

Speaker: Assistant Professor C. Zuurbier (Amsterdam, NL)

SGLT2-inhibitors and iron status in heart failure

Speaker: Doctor J. Nunez Villota (Valencia, ES)

The cardioprotective effects of semaglutide exceed those of dietary weight loss in mice with HFpEF

Speaker: Professor R. De Boer (Rotterdam, NL)

Access the full session

The cardiometabolic syndrome and extracardiac drug effects beneficial to the heart

Speakers: Professor L. Bertrand, Assistant Professor C. Zuurbier, Doctor J. Nunez Villota, Professor R. De Boer

About the event

HFA Winter Research Meeting on Translational Heart Failure 2025

20 January - 22 January 2025

Seminar

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources